Showing results (991-1000 of 2,017) with videos related to

Sort By:
Pageof 202
Annals of Hepatology|May 11, 2026
Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosisYujie Zhang, Ruoting Men, Yi Shen, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
Annals of Hepatology|June 11, 2026
Secondary prophylaxis of SBP in cirrhosis: trimethoprim-sulfamethoxazole vs. ciprofloxacin in a propensity-matched cohortMohamad Mahdi Osman, Omar T Sims, Dian J Chiang
Annals of Hepatology|June 12, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation eventLorenz Balcars, Adrian Wunderbaldinger, Lucie Simonis, et al.
Annals of Hepatology|May 3, 2026
Mesencephalic astrocyte-derived neurotrophic factor (MANF): a context-dependent therapeutic regulator and potential biomarker in liver diseasesYu Liu, Hao-Wen Wang, Li-Jun Zhang, et al.
Annals of Hepatology|January 3, 2019
An Argument for Vitamin D, A, and Zinc Monitoring in CirrhosisAndree H Koop, Omar Y Mousa, Ly Elaine Pham, et al.
Annals of Hepatology|October 31, 2012
Protective role of standardized Feronia limonia stem bark methanolic extract against carbon tetrachloride induced hepatotoxicityMahendra Jain, Rakhee Kapadia, Ravirajsinh Navalsinh Jadeja, et al.
Annals of Hepatology|October 27, 2004
Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trialNahum Méndez-Sánchez, Verónica González, Norberto Chávez-Tapia, et al.
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
Pageof 202